Physician profile
John Samuel Welsh
NPI 1891776969
$455.04
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $37.58 · 2021: $39.76 · 2022: $85.32 · 2023: $24.97 · 2024: $53.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $169.76 | 2019-2022 | |
| Abbvie INC. | $99.78 | 2019-2022 | |
| Organon LLC | $33.48 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $30.19 | 2021-2024 | Gardasil 9, Gardasil |
| Exact Sciences Corporation | $18.88 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $17.42 | 2019 | |
| Aspira Women'S Health INC | $14.55 | 2022 | |
| Scynexis, INC. | $12.97 | 2022 | |
| Becton, Dickinson and Company | $12.72 | 2023 | Bd Onclarity |
| Meditrina | $12.25 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.47 | 2019 | |
| Therapeuticsmd, INC. | $10.84 | 2019 | |
| Daiichi Sankyo INC. | $10.73 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Welsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.